J S Schneider Selected Research

MPTP Poisoning

8/2008	Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
11/2003	Development of levodopa-induced dyskinesias in parkinsonian monkeys may depend upon rate of symptom onset and/or duration of symptoms.
8/2002	GABA-opioid interactions in the globus pallidus: [D-Ala2]-Met-enkephalinamide attenuates potassium-evoked GABA release after nigrostriatal lesion.
8/2001	Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.
6/2001	Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism.
1/2001	Alterations in expression of messenger RNAs encoding two isoforms of glutamic acid decarboxylase in the globus pallidus and entopeduncular nucleus in animals symptomatic for and recovered from experimental Parkinsonism.
6/2000	Striatal enkephalin gene expression does not reflect parkinsonian signs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J S Schneider Research Topics

Disease

13	Parkinson Disease (Parkinson's Disease) 01/2022 - 04/2000
11	Parkinsonian Disorders (Parkinsonism) 08/2010 - 03/2000
7	MPTP Poisoning 08/2008 - 06/2000
4	Cognitive Dysfunction 01/2020 - 07/2001
2	Dyskinesias (Dyskinesia) 01/2020 - 11/2003
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014 - 10/2011
2	Huntington Disease (Huntington's Disease) 01/2014 - 10/2011
1	Major Depressive Disorder (Major Depressive Disorders) 01/2019
1	Schizophrenia (Dementia Praecox) 01/2019
1	Autism Spectrum Disorder 01/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Movement Disorders (Movement Disorder) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2014
1	Gaucher Disease (Gaucher's Disease) 01/2014
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2011
1	Inflammation (Inflammations) 10/2011
1	Memory Disorders (Memory Loss) 03/2009
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2004
1	Lordosis 04/2001

Drug/Important Bio-Agent (IBA)

13	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2011 - 05/2000
9	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 04/2000
5	Messenger RNA (mRNA)IBA 08/2001 - 06/2000
3	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 11/2003
2	NeurotoxinsIBA 08/2010 - 10/2006
1	G(M1) GangliosideIBA 01/2022
1	Histones (Histone)IBA 01/2019
1	LipidsIBA 01/2018
1	GlycolipidsIBA 01/2014
1	GangliosidesIBA 01/2014
1	Histone Deacetylase InhibitorsIBA 10/2011
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2011
1	PyrrolidinesIBA 10/2011
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2011
1	Clonidine (ST 155)FDA LinkGeneric 08/2010
1	ManganeseIBA 03/2009
1	Niacinamide (Nicotinamide)FDA LinkGeneric 08/2008
1	Nicotine FDA Link 10/2006
1	4- ((2- (1- methyl- 2- pyrrolidinyl)ethyl)thio)phenol hydrochlorideIBA 10/2006
1	RV 538 (PDMP)IBA 07/2006
1	CeramidesIBA 07/2006
1	Ac- Nal(1)- Cpa(2)- Pal(3,6)- Arg(5)- Ala(10)- LHRHIBA 07/2006
1	gamma-Aminobutyric Acid (GABA)IBA 08/2002
1	PotassiumIBA 08/2002
1	Opioid Receptors (Opioid Receptor)IBA 08/2002
1	NeuropeptidesIBA 02/2002
1	S 17092-1IBA 02/2002
1	EnzymesIBA 02/2002
1	Prolyl OligopeptidasesIBA 02/2002
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 08/2001
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 08/2001
1	Proteins (Proteins, Gene)FDA Link 08/2001
1	Dopamine D3 ReceptorsIBA 06/2001
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2001
1	GonadotropinsIBA 04/2001
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 04/2001
1	Follicle Stimulating Hormone (Follitropin)FDA Link 04/2001
1	Protein Isoforms (Isoforms)IBA 01/2001
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2001
1	preproenkephalinIBA 06/2000
1	Dopamine Receptors (Dopamine Receptor)IBA 05/2000
1	Cycloserine (Seromycin)FDA Link 03/2000

Therapy/Procedure

5	Therapeutics 08/2010 - 06/2001
1	Denervation 07/2001